Deletion of the Npr3 gene increases severity of acute lung injury in obese mice
暂无分享,去创建一个
[1] A. Alli,et al. C Type Natriuretic Peptide Receptor Activation Inhibits Sodium Channel Activity in Human Aortic Endothelial Cells by Activating the Diacylglycerol-Protein Kinase C Pathway , 2022, International journal of molecular sciences.
[2] Zachary S. Wilson,et al. Natriuretic Peptide Receptor-C mediates the inhibitory Effect of Atrial Natriuretic Peptide on Neutrophil Recruitment to the Lung during Acute Lung Injury. , 2022, American journal of physiology. Lung cellular and molecular physiology.
[3] Dao-xin Wang,et al. Adipose-Derived Circulating Exosomes Promote Protection of the Pulmonary Endothelial Barrier by Inhibiting EndMT and Oxidative Stress through Down-Regulation of the TGF-β Pathway: A Potential Explanation for the Obesity Paradox in ARDS , 2022, Oxidative medicine and cellular longevity.
[4] M. Beudel,et al. Overweight and Obesity Are Associated With Acute Kidney Injury and Acute Respiratory Distress Syndrome, but Not With Increased Mortality in Hospitalized COVID-19 Patients: A Retrospective Cohort Study , 2021, Frontiers in Endocrinology.
[5] O. Ziegler,et al. Obesity and mortality in critically ill COVID-19 patients with respiratory failure , 2021, International Journal of Obesity.
[6] E. Egom. Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF) , 2021, Frontiers in Physiology.
[7] Karin de Punder,et al. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review , 2021, Cells.
[8] L. Nagy,et al. Diet-dependent natriuretic peptide receptor C expression in adipose tissue is mediated by PPARγ via long-range distal enhancers , 2021, bioRxiv.
[9] M. Zeitlinger,et al. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey , 2020, Critical Care.
[10] A. Hobbs,et al. C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature , 2019, International journal of molecular sciences.
[11] He Yu,et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis , 2017, Critical Care.
[12] Liu Shuying,et al. “Obesity Paradox” in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis , 2016, PloS one.
[13] Anders Larsson,et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.
[14] Hao Wang,et al. Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). , 2015, Gene.
[15] D. Joanisse,et al. Defective Natriuretic Peptide Receptor Signaling in Skeletal Muscle Links Obesity to Type 2 Diabetes , 2015, Diabetes.
[16] R. Lucas,et al. The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches. , 2015, Austin journal of vascular medicine.
[17] M. Okumura,et al. Atrial natriuretic peptide inhibits lipopolysaccharide-induced acute lung injury. , 2014, Pulmonary pharmacology & therapeutics.
[18] K. Skaltsa,et al. Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay , 2014, BMC Anesthesiology.
[19] J. Machan,et al. Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A. , 2013, Journal of applied physiology.
[20] A. Malhotra,et al. Obesity and ARDS. , 2012, Chest.
[21] D. Mohapatra,et al. The C-Type Natriuretic Peptide Induces Thermal Hyperalgesia through a Noncanonical Gβγ-dependent Modulation of TRPV1 Channel , 2012, The Journal of Neuroscience.
[22] L. Potter. Natriuretic peptide metabolism, clearance and degradation , 2011, The FEBS journal.
[23] D. Christiani,et al. Body mass index and acute kidney injury in the acute respiratory distress syndrome , 2011, Critical care medicine.
[24] K. Nakao,et al. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. , 2011, Journal of cardiology.
[25] N. O. Belo,et al. Natriuretic peptide system: A link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats , 2011, Regulatory Peptides.
[26] A. Klibanov,et al. Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[27] L. Nielsen,et al. Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. , 2010, Endocrinology.
[28] P. Parsons,et al. The association between BMI and plasma cytokine levels in patients with acute lung injury. , 2010, Chest.
[29] E. Bajwa,et al. Body mass index is associated with the development of acute respiratory distress syndrome , 2009, Thorax.
[30] Elena Alekseeva,et al. Epac/Rap and PKA are novel mechanisms of ANP‐induced Rac‐mediated pulmonary endothelial barrier protection , 2008, Journal of cellular physiology.
[31] J. Sznajder,et al. Alveolar epithelium and Na,K-ATPase in acute lung injury , 2007, Intensive Care Medicine.
[32] G. Marcus,et al. Obese patients have lower B-type and atrial natriuretic peptide levels compared with nonobese. , 2006, Congestive heart failure.
[33] S. Lemeshow,et al. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury* , 2006, Critical Care Medicine.
[34] N. Maeda,et al. The role of natriuretic peptides in cardioprotection. , 2006, Cardiovascular research.
[35] D. Irwin,et al. Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[36] D. Levy,et al. Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.
[37] R. Macallister,et al. Vascular natriuretic peptide receptor‐linked particulate guanylate cyclases are modulated by nitric oxide–cyclic GMP signalling , 2003, British journal of pharmacology.
[38] T. Hunter,et al. Guanylyl Cyclase-linked Natriuretic Peptide Receptors: Structure and Regulation* , 2001, The Journal of Biological Chemistry.
[39] H. Zhou,et al. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[40] M. Yamauchi,et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] Y. Hirata,et al. Beneficial effect of atrial natriuretic peptide on pulmonary gas exchange in patients with acute lung injury. , 1998, Chest.
[42] M. Kitajima,et al. Effect of acute lung injury and coexisting disorders on plasma concentrations of atrial natriuretic peptide , 1994, Critical care medicine.
[43] R. A. Rutherford,et al. Identification of renal natriuretic peptide receptor subpopulations by use of the non‐peptide antagonist, HS‐142‐1 , 1994, British journal of pharmacology.
[44] M. Volpe,et al. Salt‐Regulating Hormones in Young Normotensive Obese Subjects: Effects of Saline Load , 1994, Hypertension.
[45] N. Minamino,et al. C-type natriuretic peptide inhibits intimal thickening after vascular injury. , 1993, Biochemical and biophysical research communications.
[46] D. Goeddel,et al. Molecular Biology of the Natriuretic Peptides and Their Receptors , 1992, Circulation.
[47] A. Birukova,et al. Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction. , 2011, Journal of applied physiology.
[48] M. Emdin,et al. The paradox of low BNP levels in obesity , 2011, Heart Failure Reviews.
[49] L. R. Potter,et al. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. , 2009, Handbook of experimental pharmacology.